Premium
Giant cell arteritis with visual loss following zoledronic acid infusion
Author(s) -
Metyas Samy,
Ibrahim Makary,
Solyman John,
Yeter Karen C.,
Arkfeld Daniel G.
Publication year - 2014
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.12263
Subject(s) - medicine , zoledronic acid , giant cell arteritis , arteritis , dermatology , vasculitis , disease
Zoledronic acid is used in the treatment of osteoporosis. Giant cell artertitis may lead to vision loss. We report a case in which vision loss occurred after zoledronic acid infusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom